Development of glycan-based antimicrobial therapies - Texte

zur Starseite
zur Hauptnavigation
zum Inhalt
zur Suche
zur Hilfe

Schrift Standard Fett
Login

Forschungsstelle

INNOSUISSE

Projektnummer

104.462.1 IP-LS

Projekttitel

Development of glycan-based antimicrobial therapies

Projekttitel Englisch

Development of glycan-based antimicrobial therapies

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Kurzbeschreibung		-	-
Abstract		-	-

Erfasste Texte

Kategorie	Text
Kurzbeschreibung (Deutsch)	Development of glycan-based antimicrobial therapies
Kurzbeschreibung (Englisch)	Development of glycan-based antimicrobial therapies
Abstract (Deutsch)	Antimicrobial resistance is reaching a global crisis and the WHO considers it a major health threat. Alternative therapies for infection are urgently needed, therefore we have developed a novel drug class targeting a range of pathogens while retaining natural flora to restore microbiome homeostasis.
Abstract (Englisch)	Antimicrobial resistance is reaching a global crisis and the WHO considers it a major health threat. Alternative therapies for infection are urgently needed, therefore we have developed a novel drug class targeting a range of pathogens while retaining natural flora to restore microbiome homeostasis.